Dec 21 (Reuters) - Antibe Therapeutics Inc ATE.V :
* Announces completion of validation studies of atb-346, progression to phase 2
clinical trials
* Says Antibe plans to move forward with phase 2 studies and will submit an
application to health Canada in early 2016
* Source text for Eikon ID:nBwbTDjFQa
* Further company coverage ATE.V